Symbols / OMDA Stock $14.69 -0.88% Omada Health, Inc.

Healthcare • Health Information Services • United States • NMS
OMDA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Sean P. Duffy
Exch · Country NMS · United States
Market Cap 872.81M
Enterprise Value 669.26M
Income -6.30M
Sales 283.30M
FCF (ttm) 16.81M
Book/sh 3.93
Cash/sh 3.56
Employees 916
Insider 10d —
IPO Jun 06, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 32.37
PEG —
P/S 3.08
P/B 3.74
P/C —
EV/EBITDA -248.70
EV/Sales 2.36
Quick Ratio 3.69
Current Ratio 3.92
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -0.21
EPS next Y 0.45
EPS Growth —
Revenue Growth 42.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-07
ROA -2.35%
ROE -4.30%
ROIC —
Gross Margin 66.27%
Oper. Margin -6.13%
Profit Margin -2.22%
Shs Outstand 59.42M
Shs Float 43.96M
Insider Own 2.19%
Instit Own 87.80%
Short Float 6.87%
Short Ratio 3.37
Short Interest 3.66M
52W High 28.40
vs 52W High -48.27%
52W Low 10.28
vs 52W Low 42.90%
Beta —
Impl. Vol. 95.70%
Rel Volume 1.12
Avg Volume 1.29M
Volume 1.44M
Target (mean) $22.92
Tgt Median $22.50
Tgt Low $14.00
Tgt High $30.00
# Analysts 12
Recom Buy
Prev Close $14.82
Price $14.69
Change -0.88%
About

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$22.92
Mean price target
2. Current target
$14.69
Latest analyst target
3. DCF / Fair value
$5.09
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$14.69
Low
$14.00
High
$30.00
Mean
$22.92

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-08 main Barclays Overweight → Overweight $20
2026-05-08 main Citizens Market Outperform → Market Outperform $21
2026-05-08 main Evercore ISI Group Outperform → Outperform $20
2026-05-08 main Wells Fargo Equal-Weight → Equal-Weight $18
2026-05-08 reit Needham Buy → Buy $28
2026-04-14 init Citizens — → Market Outperform $18
2026-04-09 main Goldman Sachs Buy → Buy $23
2026-04-08 main Evercore ISI Group Outperform → Outperform $15
2026-03-12 main JP Morgan Overweight → Overweight $26
2026-03-06 main Canaccord Genuity Buy → Buy $22
2026-03-06 main BMO Capital Outperform → Outperform $18
2026-03-06 main Morgan Stanley Overweight → Overweight $30
2026-03-06 main Barclays Overweight → Overweight $18
2026-03-03 main Barclays Overweight → Overweight $17
2026-01-22 reit Needham Buy → Buy $28
2026-01-09 init Wells Fargo — → Equal-Weight $17
2026-01-05 main Barclays Overweight → Overweight $22
2025-11-13 init BMO Capital — → Outperform $27
2025-11-07 main Barclays Overweight → Overweight $29
2025-11-07 main Evercore ISI Group Outperform → Outperform $28
News
RSS: Latest OMDA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-08 SHAO WEI-LI President — 2,829 $12.71 $35,946
2026-04-02 KLAPSTEIN JULIE D Director — 698 $0.00 $0
2026-04-02 HILLEMAN JERYL L Director — 1,544 $0.00 $0
2026-04-02 FETTER TREVOR Director — 955 $0.00 $0
2026-04-02 ROOT JONATHAN D Director — 882 $0.00 $0
2026-03-13 COOK STEVEN L. Chief Financial Officer — 1,884 $13.94 $26,263
2026-03-09 DUFFY SEAN P M.D. Chief Executive Officer — 4,063 $14.32 $58,276
2026-03-05 GRACEY CRAIG Officer — 16,470 $0.00 $0
2026-03-05 COOK STEVEN L. Chief Financial Officer — 147,058 $0.00 $0
2026-03-05 DUFFY SEAN P M.D. Chief Executive Officer — 323,529 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
260.21
+53.24%
169.80
+38.29%
122.78
+37.67%
89.19
Operating Revenue
260.21
+53.24%
169.80
+38.29%
122.78
+37.67%
89.19
Cost Of Revenue
89.27
+33.39%
66.92
+26.72%
52.81
+13.84%
46.39
Reconciled Cost Of Revenue
89.27
+33.39%
66.92
+26.72%
52.81
+13.84%
46.39
Gross Profit
170.94
+66.16%
102.88
+47.03%
69.97
+63.52%
42.79
Operating Expense
182.91
+24.83%
146.53
+7.77%
135.97
+18.09%
115.14
Research And Development
40.68
+13.25%
35.92
+6.48%
33.74
+28.93%
26.17
Selling General And Administration
142.23
+28.59%
110.61
+8.20%
102.23
+14.90%
88.97
Selling And Marketing Expense
90.04
+32.31%
68.05
+2.72%
66.25
+13.28%
58.48
General And Administrative Expense
52.18
+22.63%
42.55
+18.27%
35.98
+18.01%
30.49
Other Gand A
52.18
+22.63%
42.55
+18.27%
35.98
+18.01%
30.49
Total Expenses
272.18
+27.51%
213.45
+13.07%
188.78
+16.87%
161.53
Operating Income
-11.97
+72.58%
-43.65
+33.85%
-66.00
+8.78%
-72.35
Total Operating Income As Reported
-11.97
+72.58%
-43.65
+33.85%
-66.00
+8.78%
-72.35
EBITDA
-4.75
+87.44%
-37.83
+35.18%
-58.36
+8.80%
-63.99
Normalized EBITDA
-1.18
+96.91%
-38.05
+31.79%
-55.77
+15.26%
-65.82
Reconciled Depreciation
5.49
+14.32%
4.80
+7.98%
4.45
+2.70%
4.33
EBIT
-10.24
+75.97%
-42.63
+32.12%
-62.81
+8.07%
-68.32
Total Unusual Items
-3.58
-1740.83%
0.22
+108.44%
-2.58
-241.13%
1.83
Total Unusual Items Excluding Goodwill
-3.58
-1740.83%
0.22
+108.44%
-2.58
-241.13%
1.83
Special Income Charges
-2.11
0.00
+100.00%
-1.54
0.00
Other Special Charges
2.11
—
1.54
—
Net Income
-12.78
+72.89%
-47.14
+30.18%
-67.51
+6.90%
-72.52
Pretax Income
-12.78
+72.89%
-47.14
+30.18%
-67.51
+6.90%
-72.52
Net Non Operating Interest Income Expense
2.77
+174.87%
-3.70
-445.89%
1.07
+153.53%
-2.00
Interest Expense Non Operating
2.53
-43.76%
4.51
-4.23%
4.71
+12.00%
4.20
Net Interest Income
2.77
+174.87%
-3.70
-445.89%
1.07
+153.53%
-2.00
Interest Expense
2.53
-43.76%
4.51
-4.23%
4.71
+12.00%
4.20
Interest Income Non Operating
5.30
+559.01%
0.81
-86.06%
5.78
+162.26%
2.20
Interest Income
5.30
+559.01%
0.81
-86.06%
5.78
+162.26%
2.20
Other Income Expense
-3.58
-1740.83%
0.22
+108.44%
-2.58
-241.13%
1.83
Gain On Sale Of Security
-1.47
-773.39%
0.22
+120.80%
-1.05
-157.24%
1.83
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-12.78
+72.89%
-47.14
+30.18%
-67.51
+6.90%
-72.52
Net Income From Continuing Operation Net Minority Interest
-12.78
+72.89%
-47.14
+30.18%
-67.51
+6.90%
-72.52
Net Income From Continuing And Discontinued Operation
-12.78
+72.89%
-47.14
+30.18%
-67.51
+6.90%
-72.52
Net Income Continuous Operations
-12.78
+72.89%
-47.14
+30.18%
-67.51
+6.90%
-72.52
Normalized Income
-9.20
+80.57%
-47.35
+27.06%
-64.93
+12.67%
-74.35
Net Income Common Stockholders
-12.78
+72.89%
-47.14
+30.18%
-67.51
+6.90%
-72.52
Otherunder Preferred Stock Dividend
—
0.20
—
—
Diluted EPS
-0.35
+58.61%
-0.85
+40.23%
-1.41
+6.90%
-1.52
Basic EPS
-0.35
+58.61%
-0.85
+40.23%
-1.41
+6.90%
-1.52
Basic Average Shares
36.64
-34.27%
55.74
+16.81%
47.72
+0.00%
47.72
Diluted Average Shares
36.64
-34.27%
55.74
+16.81%
47.72
+0.00%
47.72
Diluted NI Availto Com Stockholders
-12.78
+72.89%
-47.14
+30.18%
-67.51
+6.90%
-72.52
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
305.41
+102.40%
150.89
-13.82%
175.08
-21.06%
221.80
Current Assets
272.93
+141.41%
113.06
-20.87%
142.88
-24.22%
188.56
Cash Cash Equivalents And Short Term Investments
222.04
+190.65%
76.39
-33.94%
115.64
-31.22%
168.12
Cash And Cash Equivalents
222.04
+190.65%
76.39
-33.94%
115.64
-31.22%
168.12
Receivables
35.22
+47.26%
23.92
+45.51%
16.44
+40.89%
11.67
Accounts Receivable
13.56
+43.02%
9.48
+25.14%
7.58
+53.59%
4.93
Gross Accounts Receivable
—
25.40
+49.41%
17.00
+43.88%
11.82
Allowance For Doubtful Accounts Receivable
—
-1.99
-215.08%
-0.63
-90.91%
-0.33
Receivables Adjustments Allowances
-1.16
+41.56%
-1.99
-215.08%
-0.63
-90.91%
-0.33
Other Receivables
22.82
+38.97%
16.42
+73.03%
9.49
+34.36%
7.06
Inventory
4.49
+36.10%
3.30
-8.80%
3.61
+2.09%
3.54
Finished Goods
—
3.30
-8.80%
3.61
—
Prepaid Assets
5.76
+34.11%
4.29
+31.27%
3.27
+10.43%
2.96
Current Deferred Assets
3.54
+17.30%
3.02
+39.29%
2.17
+19.60%
1.81
Other Current Assets
1.89
-11.68%
2.14
+22.57%
1.75
+287.14%
0.45
Total Non Current Assets
32.47
-14.17%
37.83
+17.49%
32.20
-3.13%
33.24
Net PPE
7.94
+30.80%
6.07
+8.47%
5.60
-7.65%
6.06
Gross PPE
19.76
+20.18%
16.44
+21.13%
13.57
+7.97%
12.57
Accumulated Depreciation
-11.82
-13.97%
-10.37
-30.02%
-7.98
-22.52%
-6.51
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
19.76
+30.29%
15.17
+31.09%
11.57
+17.04%
9.89
Other Properties
—
0.45
-61.96%
1.18
-36.76%
1.86
Leases
0.00
-100.00%
0.83
+0.00%
0.83
+0.00%
0.83
Goodwill And Other Intangible Assets
15.65
-10.56%
17.50
-10.29%
19.51
-9.48%
21.55
Goodwill
13.24
+0.00%
13.24
+0.00%
13.24
+0.00%
13.24
Other Intangible Assets
2.41
-43.37%
4.26
-32.01%
6.27
-24.59%
8.31
Non Current Deferred Assets
8.71
-5.46%
9.21
+42.59%
6.46
+31.42%
4.92
Other Non Current Assets
0.17
-96.73%
5.04
+699.37%
0.63
-11.13%
0.71
Total Liabilities Net Minority Interest
75.73
-85.85%
535.29
+602.87%
76.16
+15.05%
66.19
Current Liabilities
75.73
+40.36%
53.95
+23.21%
43.79
+26.88%
34.51
Payables And Accrued Expenses
26.12
+102.66%
12.89
+2.09%
12.63
+21.02%
10.43
Payables
10.28
+146.55%
4.17
+15.11%
3.62
-11.83%
4.11
Accounts Payable
10.28
+146.55%
4.17
+15.11%
3.62
-11.83%
4.11
Current Accrued Expenses
15.85
+81.69%
8.72
-3.14%
9.01
+42.35%
6.33
Pensionand Other Post Retirement Benefit Plans Current
24.55
+16.23%
21.12
+36.32%
15.49
+57.62%
9.83
Current Debt And Capital Lease Obligation
—
0.41
-47.27%
0.79
+21.45%
0.65
Current Capital Lease Obligation
0.00
-100.00%
0.41
-47.27%
0.79
+21.45%
0.65
Current Deferred Liabilities
25.06
+28.31%
19.53
+31.21%
14.88
+10.73%
13.44
Current Deferred Revenue
25.06
+28.31%
19.53
+31.21%
14.88
+10.73%
13.44
Other Current Liabilities
—
—
—
0.16
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
481.34
+1387.09%
32.37
+2.17%
31.68
Long Term Debt And Capital Lease Obligation
—
29.77
-0.07%
29.79
-1.22%
30.16
Long Term Debt
—
29.77
+1.32%
29.38
+1.69%
28.89
Long Term Capital Lease Obligation
—
0.00
-100.00%
0.41
-67.54%
1.27
Other Non Current Liabilities
—
0.28
+171.43%
0.10
—
Preferred Securities Outside Stock Equity
0.00
-100.00%
449.03
—
—
Stockholders Equity
229.68
+159.75%
-384.40
-488.59%
98.92
-36.43%
155.60
Common Stock Equity
229.68
+159.75%
-384.40
-9.79%
-350.11
-19.42%
-293.17
Capital Stock
0.06
+625.00%
0.01
-100.00%
449.04
+0.05%
448.80
Common Stock
0.06
+625.00%
0.01
+14.29%
0.01
-66.67%
0.02
Preferred Stock
—
449.03
+0.00%
449.03
+0.06%
448.78
Share Issued
58.43
+4.82%
55.74
+0.00%
55.74
+0.00%
55.74
Ordinary Shares Number
58.43
+4.82%
55.74
+0.00%
55.74
+0.00%
55.74
Additional Paid In Capital
686.37
+1052.49%
59.55
+27.50%
46.71
+29.30%
36.12
Retained Earnings
-456.74
-2.88%
-443.97
-11.88%
-396.83
-20.50%
-329.32
Total Equity Gross Minority Interest
229.68
+159.75%
-384.40
-488.59%
98.92
-36.43%
155.60
Total Capitalization
229.68
+164.77%
-354.63
-376.40%
128.30
-30.46%
184.50
Working Capital
197.21
+233.65%
59.11
-40.35%
99.09
-35.67%
154.04
Invested Capital
229.68
+164.77%
-354.63
-10.57%
-320.73
-21.36%
-264.28
Total Debt
0.00
-100.00%
30.19
-1.29%
30.58
-0.74%
30.81
Capital Lease Obligations
0.00
-100.00%
0.41
-65.36%
1.20
-37.41%
1.91
Net Tangible Assets
214.03
+153.25%
-401.91
-606.10%
79.41
-40.76%
134.05
Tangible Book Value
214.03
+153.25%
-401.91
-8.73%
-369.62
-17.44%
-314.73
Derivative Product Liabilities
0.00
-100.00%
2.25
-8.83%
2.47
+62.50%
1.52
Preferred Stock Equity
—
449.03
+0.00%
449.03
+0.06%
448.78
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
18.25
+153.40%
-34.18
+31.28%
-49.74
+27.90%
-68.98
Cash Flow From Continuing Operating Activities
18.25
+153.40%
-34.18
+31.28%
-49.74
+27.90%
-68.98
Net Income From Continuing Operations
-12.78
+72.89%
-47.14
+30.18%
-67.51
+6.90%
-72.52
Depreciation Amortization Depletion
5.49
+14.32%
4.80
+7.98%
4.45
+2.70%
4.33
Depreciation And Amortization
5.49
+14.32%
4.80
+7.98%
4.45
+2.70%
4.33
Other Non Cash Items
4.07
+8.27%
3.76
+29.74%
2.90
-11.75%
3.28
Stock Based Compensation
12.96
+37.53%
9.42
+7.78%
8.74
+31.35%
6.65
Provisionand Write Offof Assets
1.19
-32.44%
1.76
+289.38%
0.45
+89.12%
0.24
Operating Gains Losses
3.58
+1759.72%
-0.22
-107.90%
2.73
+249.86%
-1.82
Gain Loss On Investment Securities
1.47
+773.39%
-0.22
-120.80%
1.05
+157.24%
-1.83
Gain Loss On Sale Of PPE
0.01
+300.00%
0.00
-98.68%
0.15
+2416.67%
0.01
Change In Working Capital
3.74
+156.92%
-6.57
-337.93%
-1.50
+83.60%
-9.14
Change In Receivables
-12.36
-40.34%
-8.80
-64.98%
-5.34
-35.66%
-3.93
Changes In Account Receivables
-12.36
-40.34%
-8.80
-64.98%
-5.34
-35.66%
-3.93
Change In Inventory
-1.19
-474.21%
0.32
+529.73%
-0.07
+96.21%
-1.95
Change In Prepaid Assets
-1.41
+23.96%
-1.85
-24.36%
-1.49
-176.44%
-0.54
Change In Payables And Accrued Expense
16.84
+193.30%
5.74
-28.72%
8.06
+7428.97%
0.11
Change In Accrued Expense
10.55
+97.49%
5.34
-35.95%
8.34
+63.83%
5.09
Change In Payable
6.29
+1476.19%
0.40
+239.51%
-0.29
+94.26%
-4.99
Change In Account Payable
6.29
+1476.19%
0.40
+239.51%
-0.29
+94.26%
-4.99
Change In Other Working Capital
5.53
+19.01%
4.64
+222.12%
1.44
-19.22%
1.78
Change In Other Current Assets
-3.26
+45.80%
-6.01
-72.49%
-3.49
-4.31%
-3.34
Change In Other Current Liabilities
-0.41
+31.18%
-0.60
+1.31%
-0.61
+51.93%
-1.27
Investing Cash Flow
-5.83
-50.97%
-3.86
-32.25%
-2.92
-7.35%
-2.72
Cash Flow From Continuing Investing Activities
-5.83
-50.97%
-3.86
-32.25%
-2.92
-7.35%
-2.72
Net PPE Purchase And Sale
-1.32
-121.81%
-0.60
-43.27%
-0.42
+42.22%
-0.72
Purchase Of PPE
-1.32
-121.81%
-0.60
-43.27%
-0.42
+42.22%
-0.72
Capital Expenditure
-5.83
-50.97%
-3.86
-32.25%
-2.92
-7.35%
-2.72
Capital Expenditure Reported
-4.51
-38.05%
-3.27
-30.42%
-2.50
—
Net Intangibles Purchase And Sale
—
-3.27
-30.42%
-2.50
-25.19%
-2.00
Purchase Of Intangibles
—
-3.27
-30.42%
-2.50
-25.19%
-2.00
Financing Cash Flow
133.22
+11119.35%
-1.21
-775.42%
0.18
-98.90%
16.32
Cash Flow From Continuing Financing Activities
133.22
+11119.35%
-1.21
-775.42%
0.18
-98.90%
16.32
Net Issuance Payments Of Debt
-30.96
0.00
-100.00%
0.96
0.00
Issuance Of Debt
0.00
0.00
-100.00%
30.96
0.00
Repayment Of Debt
-30.96
0.00
+100.00%
-30.00
0.00
Long Term Debt Issuance
0.00
0.00
-100.00%
30.96
0.00
Long Term Debt Payments
-30.96
0.00
+100.00%
-30.00
0.00
Net Long Term Debt Issuance
-30.96
0.00
-100.00%
0.96
0.00
Net Common Stock Issuance
160.53
0.00
0.00
-100.00%
1.74
Proceeds From Stock Option Exercised
9.37
+181.41%
3.33
+89.69%
1.75
—
Net Other Financing Charges
-5.71
-25.89%
-4.54
-78.73%
-2.54
—
Changes In Cash
145.64
+471.06%
-39.25
+25.21%
-52.48
+5.24%
-55.38
Beginning Cash Position
76.39
-33.94%
115.64
-31.22%
168.12
-24.78%
223.50
End Cash Position
222.04
+190.65%
76.39
-33.94%
115.64
-31.22%
168.12
Free Cash Flow
12.42
+132.65%
-38.04
+27.76%
-52.66
+26.56%
-71.70
Interest Paid Supplemental Data
2.42
-37.21%
3.85
-5.89%
4.09
+13.56%
3.61
Amortization Of Securities
—
3.03
+36.88%
2.21
+19.86%
1.85
Common Stock Issuance
160.53
0.00
0.00
-100.00%
1.74
Issuance Of Capital Stock
160.53
0.00
0.00
-100.00%
16.32
Net Preferred Stock Issuance
—
—
0.00
-100.00%
14.58
Preferred Stock Issuance
—
—
0.00
-100.00%
14.58
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category